Table 2.
Diabetes | Baseline | 6 months | 12 months | |
---|---|---|---|---|
BMI (kg/m2) | YES | 47 ± 8 | 35 ± 6*† | 32 ± 6‡ |
NO | 48 ± 8 | 35 ± 7*† | 31 ± 6‡ | |
Plasma creatinine (mg/dl) |
YES | 0.64 ± 0.11 | 0.63 ± 0.09 | 0.63 ± 0.09 |
NO | 0.72 ± 0.12 | 0.68 ± 0.15 | 0.71 ± 0.11 | |
Urinary cystatin (µg/day) |
YES | 81 ± 58 | 90 ± 35 | 83 ± 40 |
NO | 71 ± 33 | 55 ± 26 | 75 ± 31 | |
Urinary creatinine (mg/day) |
YES | 14.7± 5.9 | 10.9 ± 4.9* | 12 ± 3.4‡ |
NO | 14.4 ± 4.4 | 9.6 ± 4.2*† | 12.4 ± 3.6 | |
Urinary albumin (mg/day) |
YES | 26 ± 50 | 18 ± 33 | 15 ± 29 |
NO | 10 ± 6 | 5 ± 2*† | 14 ± 20 | |
Urinary protein (mg/day) |
YES | 181 ± 165 | 109 ± 68 | 133 ± 67 |
NO | 122 ± 53 | 80 ± 39† | 125 ± 58 |
BMI, body mass index. RYGB, Roux-en-Y gastric bypass.
Data expressed as mean ± SD.
p<0.05, baseline vs. 6 months;
p<0.05, 6 months vs. 12 months;
p<0.05, baseline vs. 12 months. (nonparametric, Wilcoxon signed-rank test)